SEARCH
GO
Adequan® Canine Home
Canine Joint Disease
Clinical Signs of Canine Arthritis
About Adequan® Canine
Key Points
How Adequan® Canine Works
How Adequan® Canine is Different
Efficacy and Safety
Dosage
FAQ
Clinical Studies
Ordering

DOG OWNER INFORMATION
Dog Owners
Return to Dog Owner Information
Home  | About Adequan® Canine  | Dosage

Dosage

Dosage

The recommended dose of Adequan® Canine (polysulfated glycosaminoglycan) is 2 mg/lb body weight (.02 mL/lb, or 1 mL per 50 lb), by intramuscular injection only, twice weekly for up to 4 weeks (maximum of 8 injections). Do not exceed the recommended dose or therapeutic regimen.
Product Information
Product Information
Click Here
Did You Know ...
Did You Know?

About 20% of all adult dogs in the U.S. suffer from canine arthritis.
Adequan® Canine (polysulfated glycosaminoglycan or PSGAG) should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Possible side effects (pain at injection site, diarrhea and abnormal bleeding) were mild, transient and self-limiting. Safety studies of PSGAG in breeding, pregnant or lactating dogs have not been conducted. Click here for full product information.


 
Interwoven VisualPreview: //nov-cont04.novartispharmaceutical.com/us/main/www.milbemite.novartis.us/WORKAREA/UserWorkArea/templatedata/components/opinion_lab.tpl 









































  

    
      
      
      
        
                                                    
      
    








  

    

Lockedopinion_lab.tpl
    
      
      







 































    		
  





  

  

    
      
    







 








New Form









Import









Edit









Upload









Submit